跳转到主要内容
搜索
海报

Dermal PBPK Modelling of Propylparaben with a Novel Skin Metabolism Framework

Skip to PDF content

Authors: A. Maciel Tabosa, Y. Dancik, K. Chaitanya Telaprolu, K. Thakur, C. Corpstein, L. Coleman (Certara Predictive Technologies, Sheffield, UK); Z. M. Al-Majdoub, J. Barber, A. Rostami-Hodjegan (University of Manchester, UK); S. Polak (Certara Predictive Technologies / Jagiellonian University Medical College, Krakow, Poland)

Supporting PBPK applications across drug development

Simcyp offers a comprehensive suite of PBPK modeling solutions. Learn how Simcyp can support your MIDD strategies.

了解更多关于 Simcyp

精选推荐

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification
Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA QualificationPoster

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

Integrated mechanistic modeling approaches in oncology drug development
Integrated mechanistic modeling approaches in oncology drug developmentWebinar

Integrated mechanistic modeling approaches in oncology drug development

PBPK Modeling in Lieu of Clinical Endpoint Bioequivalence Study for Generic Tazarotene Cream 0.05%
PBPK Modeling in Lieu of Clinical Endpoint Bioequivalence Study for Generic Tazarotene Cream 0.05%Poster

PBPK Modeling in Lieu of Clinical Endpoint Bioequivalence Study for Generic Tazarotene Cream 0.05%

沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software